OraSure Technologies Inc (OSUR): Net earnings per share (EPS TTM)

OSUR (OraSure Technologies, Inc.) - company brandmark

Steady demand from government clinics for OraSure Technologies (OSUR) tests supports revenues, which, combined with external raw material supplies and full control over assembly, determines the 12-month net income per share dynamics. The -0.70 mark characterizes this parameter, confirming financial stability. Future growth is expected to be driven by business diversification and the development of molecular diagnostics.

OSUR OraSure Technologies Net earnings per share for the last four quarters (07/04/2022 - 11/14/2026)

Analytical breakdowns for OraSure Technologies Inc (OSUR)

- current quotes and average value forecast:
Price Chart OraSure Technologies, Inc.|OSUR - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization OraSure|OSUR - Company Buyout Price
- business book valuation details:
Net Assets per Single Share OraSure|OSUR - Book Valuation of Business|Market Value to Book Value Ratio orasure.com|OSUR - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity OraSure Technologies|OSUR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital OraSure Corp|OSUR - Company Aggregate Debts|Debt to Book Capitalization Ratio OraSure|OSUR - Long-Term Debt Volume|Company Current Liabilities OraSure|Quick Liquidity orasure.com
- earnings and multiples data:
OSUR - Final Profit|Projected Future Earnings OraSure Technologies|OSUR - Market Cap to Earnings|Projected Price to Earnings OraSure Technologies Inc|OSUR - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio OraSure Technologies|OSUR - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) OraSure|OSUR - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth orasure.com|OSUR - Net earnings per share growth this year|Earnings growth forecast for next year OraSure Technologies
- total revenue and sales volume data:
OSUR - Company Sales Revenue|Company Projected Revenue OraSure Technologies Inc|OSUR - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio OraSure Technologies
Analysis of all company metrics:OSUR - OraSure Technologies, Inc.
Mass-produced product of OraSure Technologies, Inc.

For OraSure Technologies (OSUR), a leader in the rapid saliva diagnostics segment, this indicator combines the efficiency of FDA-approved solutions with the business's final profitability per share. By analyzing the rolling trailing twelve-month earnings per share, an investor assesses the net remaining funds after all expenses and taxes, confirming the company's ability to convert its technological advantage into sustainable capital growth.

Competitors of OraSure Technologies

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Earnings per share for the last 12 months XGN (Exagen)|Net earnings per share (EPS TTM) MDXH|LUCD (Lucid Diagnostics Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics Global)|Earnings per share for the last four quarters IMDX (imdxinc.com)|TRIB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months ProPhase Labs, Inc.|AIMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months